
Rifaflux-100
September 17, 2026
Sezifura-3 Kit
September 17, 2026Farotick CV
Farotick CV Tablets – Faropenem & Potassium Clavulanate Tablets
When resistant or severe bacterial infections require advanced oral beta-lactam therapy, Farotick CV Tablets by Grantham Lifesciences offer a potent combination of Faropenem Sodium Hydrate and Potassium Clavulanate. Each film-coated tablet contains Faropenem Sodium Hydrate JP equivalent to Faropenem 200 mg and Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid 125 mg. Combining a penem-class antibiotic with a beta-lactamase inhibitor, this formulation provides enhanced bactericidal activity against a broad spectrum of resistant pathogens under professional medical supervision.
Why Farotick CV Tablets Stand Out:
-
Synergistic Dual Formulation: Combines Faropenem 200 mg (a broad-spectrum penem antibiotic) with Clavulanic Acid 125 mg (a beta-lactamase inhibitor) to overcome bacterial resistance mechanisms.
-
Broad-Spectrum Efficacy: Effective against gram-positive, gram-negative, and anaerobic bacterial strains, including beta-lactamase-producing organisms.
-
Oral Penem Therapy: Delivers high systemic efficacy in a convenient oral tablet dosage form.
-
Convenient Packaging: Packaged as a 10x1x6 Strip (6 tablets per strip in a box of 10 strips) for structured dosage regimens.
-
Marketed by Grantham Lifesciences: Manufactured and distributed according to stringent pharmaceutical quality standards.
Uses & Indications
Farotick CV Tablets may be prescribed for the treatment of moderate to severe bacterial infections, including:
-
Respiratory Tract Infections: Community-acquired pneumonia, acute exacerbations of chronic bronchitis, sinusitis, and tonsillopharyngitis.
-
Urinary Tract Infections (UTIs): Uncomplicated and complicated UTIs, including pyelonephritis.
-
Gynecological Infections: Pelvic inflammatory conditions and obstetric/gynecological soft tissue infections.
-
Skin and Soft Tissue Infections: Severe skin infections, cellulitis, or wound infections caused by susceptible pathogens.
-
Ear, Nose, and Throat (ENT) Infections: Recurrent or resistant otitis media and sinusitis.
Key Benefits
-
Overcomes Bacterial Resistance: Clavulanic Acid protects Faropenem from degradation by beta-lactamase enzymes produced by resistant bacteria.
-
Potent Penem Antibiotic: Faropenem exhibits stable binding to penicillin-binding proteins, leading to strong bactericidal action.
-
High Oral Bioavailability: Provides dependable drug levels in tissue and serum following oral administration.
-
Convenient Oral Alternative: Serves as a reliable oral option for step-down therapy after parenteral antibiotic treatment.
Dosage & Administration
-
Farotick CV Tablets should be taken strictly as prescribed by a Registered Medical Practitioner.
-
Dosage: The exact dose, dosing frequency, and duration depend on the severity of the infection, organ function, and patient characteristics.
-
Directions:
-
Swallow the tablet whole with a glass of water.
-
Do not crush, chew, or break the tablet.
-
Take preferably with or after meals to enhance absorption and reduce potential stomach discomfort.
-
Complete the full prescribed course even if symptoms improve early.
-
Possible Side Effects
Farotick CV Tablets are generally well tolerated, but side effects may occur in some patients:
-
Diarrhea or loose stools
-
Nausea or vomiting
-
Abdominal pain or indigestion
-
Headache or dizziness
-
Mild skin rash, itching, or urticaria
-
Elevated liver enzymes (transient)
Contact a physician immediately if severe allergic reactions, severe persistent diarrhea, or signs of jaundice occur.
Precautions & Interactions
-
Hypersensitivity: Contraindicated in patients with a known history of severe allergic reactions (e.g., anaphylaxis) to penicillins, carbapenems, cephalosporins, or clavulanate.
-
Renal Impairment: Dose adjustments may be necessary for patients with reduced kidney function.
-
Pregnancy & Lactation: Should be used during pregnancy or breastfeeding only if clearly needed and advised by the physician.
-
Prescription Medicine: This product is a Schedule H Prescription Drug — to be sold by retail on the prescription of a Registered Medical Practitioner only.
Storage Instructions
-
Store in a cool, dry, and dark place.
-
Protect from light, heat, and moisture.
-
Keep out of reach of children.
-
Do not use beyond the printed expiry date on the strip.
Packaging & Product Information
-
Product Name: Farotick CV Tablets
-
Marketed by: Grantham Lifesciences
-
Dosage Form: Film-Coated Tablet
-
Composition:
-
Faropenem Sodium Hydrate JP eq. to Faropenem: 200 mg
-
Potassium Clavulanate Diluted IP eq. to Clavulanic Acid: 125 mg
-
-
Category: Antibiotic / Penem & Beta-Lactamase Inhibitor
-
Route of Administration: Oral
-
Pack Size: 10x1x6 Strip (6 Tablets per Strip)
-
MRP: ₹810/- per strip
-
GST: 5%
Frequently Asked Questions (FAQs)
Q1. What is Farotick CV Tablet used for?
A. Farotick CV Tablet is a combination antibiotic used to treat various bacterial infections, including severe respiratory tract infections, urinary tract infections, skin infections, and ENT conditions caused by resistant organisms.
Q2. What are the active ingredients in Farotick CV?
A. Each tablet contains Faropenem 200 mg (a penem-class antibiotic) and Clavulanic Acid 125 mg (a beta-lactamase inhibitor).
Q3. Why is Clavulanic Acid combined with Faropenem in Farotick CV?
A. Clavulanic Acid inhibits beta-lactamase enzymes produced by bacteria, preventing them from destroying Faropenem and making the antibiotic effective against resistant strains.
Q4. Can Farotick CV be taken without food?
A. It is generally recommended to take Farotick CV with or after meals to improve drug absorption and minimize potential stomach upset.
Q5. Can I stop taking Farotick CV once my symptoms improve?
A. No. You should complete the full course prescribed by your doctor to ensure the infection is completely treated and to prevent the development of antibiotic resistance.
Q6. Is Farotick CV available over the counter?
A. No. Farotick CV is a prescription-only antibiotic medication and must be taken under the guidance of a qualified healthcare provider.







